MENU
CTKB
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Cytek Biosciences (CTKB) Ownership - Who owns Cytek Biosciences?
Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of cell analysis tools by leveraging novel technical approaches... Show more
Profile
Industry
N/A
Address
47215 Lakeview Boulevard
Phone
+1 877 922-9835
Employees
676
Web
https://www.cytekbio.com
Details
Group
Domestic Stock Funds
Category
Medical Specialties
Capitalization
876.52M
P/E Ratio
370.37
Total Cash
262.41M
Projected Growth
N/A
Total Debt
14.14M
Revenue
193.02M
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
2.01
Total Debt/Equity
N/A
Revenue/Share
1.43 USD as % of share price
Fundamentals
CTKB
Capitalization
877M
P/E Ratio
370.37
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
262M
Total Cash/Share
2.01
Total Debt
14.1M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
1.43%
Revenue
193M
ROE
N/A
Book Value
393M
P/B Ratio
2.23
Cash Flow
N/A
Earnings
-0.09
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
131K
Current Ratio
6.97
Current Revenue Per Employee
86143.49
Dividends Per Share - Security
N/A
EBITDA
-4.41M
Float
N/A
Float - Current
N/A
Gross Income Margin
56.75
Revenue To Assets
-2.40
Shares Held By Institutions
1.01B
Shares Outstanding - Current
131M
Total Liabilities
101M
Total Volume MTD
N/A
Value
-1
Gain YTD
-42.065
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry MedicalSpecialties
Profile
Fundamentals
Details
Industry
N/A
Address
47215 Lakeview Boulevard
Phone
+1 877 922-9835
Employees
676
Web
https://www.cytekbio.com